ClinicalTrials.gg

Program

tegacorat

Also written as “GRT6019”, “Tegacorat” and “[14C]GRT6019”.

Its studies are mostly in Muscular Dystrophy, Duchenne, led by Grünenthal.

Furthest: phase 2, since Oct 27, 20264 company-led studies, 1 open or runningNext primary completion: Jan 4, 2030 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Grünenthal41 open or runningphase 2since Oct 27, 2026Dec 19, 2025Jan 4, 2030phase 2 · NCT07911995

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 19, 2025First study: phase 1 study in Muscular Dystrophy, DuchenneFirst studyNCT07317063 · 18 enrolled · United States
  2. Jan 9, 2026Phase 1 study in Muscular Dystrophy, DuchenneNCT07347548 · 24 enrolled · France
  3. Mar 13, 2026Phase 1 study in Healthy Male VolunteersNCT07479745 · 10 enrolled · United Kingdom
  4. Oct 27, 2026Phase 2 study in Muscular Dystrophy, DuchennePhase 2 reachedNCT07911995 · 36 planned

Ahead

  1. Jan 4, 2030Primary completion: phase 2 study in Muscular Dystrophy, DuchenneNCT07911995

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07911995Muscular Dystrophy, Duchenne2Not yet recruitingJan 4, 203036
NCT07479745Healthy Male Volunteers · United Kingdom1CompletedJun 18, 202610
NCT07347548Muscular Dystrophy, Duchenne · France1CompletedJun 9, 202624
NCT07317063Muscular Dystrophy, Duchenne · United States1CompletedJan 6, 202618

How it is read

Names in the registry

  • “GRT6019”, 2 entries
  • “Tegacorat”, 1 entry
  • “[14C]GRT6019”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
tegacorat (Grünenthal): development program | ClinicalTrials.gg